Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behnam Saberi

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|December 24, 2021
Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception PointsDaniela Goyes, John Paul Nsubuga, Esli Medina-Morales, et al.
Hepatology (Baltimore, Md.)|December 6, 2017
ReplyBehnam Saberi, Alia S Dadabhai, Christine M Durand, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 8, 2015
Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center ExperienceAndrew Ofosu, Christine M Durand, Behnam Saberi, et al.
Journal of Clinical Medicine|April 13, 2024
Approach to Liver Transplantation: Is There a Difference between East and West?Nazli Begum Ozturk, Nathanial Bartosek, Merih Deniz Toruner, et al.
Hepatology (Baltimore, Md.)|February 18, 2017
Challenges in treatment of hepatitis C among patients with hepatocellular carcinomaBehnam Saberi, Alia S Dadabhai, Christine M Durand, et al.
JAMA Network Open|November 2, 2023
Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy ChangeBehnam Saberi, Ahmet Gurakar, Hani Tamim, et al.
Journal of Clinical Medicine|January 11, 2022
An Update on Usage of High-Risk Donors in Liver TransplantationHaris Muhammad, Duha Zaffar, Aniqa Tehreem, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 6, 2017
Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipientBehnam Saberi, James P Hamilton, Christine M Durand, et al.
Annals of Transplantation|September 23, 2017
Single-Center Experience in Pre-transplant Hepatitis C Virus (HCV) Treatment Among Living Donor Liver Transplant Candidates: Bridging the Direct-Acting Antivirals (DAA)Ashwini M Niranjan-Azadi, Gokhan Kabacam, Christine M Durand, et al.
JAMA Network Open|December 4, 2020
Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver TransplantationBen L Da, Ghideon Ezaz, Tatyana Kushner, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|December 24, 2021
Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception PointsDaniela Goyes, John Paul Nsubuga, Esli Medina-Morales, et al.
Hepatology (Baltimore, Md.)|December 6, 2017
ReplyBehnam Saberi, Alia S Dadabhai, Christine M Durand, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 8, 2015
Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center ExperienceAndrew Ofosu, Christine M Durand, Behnam Saberi, et al.
Journal of Clinical Medicine|April 13, 2024
Approach to Liver Transplantation: Is There a Difference between East and West?Nazli Begum Ozturk, Nathanial Bartosek, Merih Deniz Toruner, et al.
Hepatology (Baltimore, Md.)|February 18, 2017
Challenges in treatment of hepatitis C among patients with hepatocellular carcinomaBehnam Saberi, Alia S Dadabhai, Christine M Durand, et al.
JAMA Network Open|November 2, 2023
Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy ChangeBehnam Saberi, Ahmet Gurakar, Hani Tamim, et al.
Journal of Clinical Medicine|January 11, 2022
An Update on Usage of High-Risk Donors in Liver TransplantationHaris Muhammad, Duha Zaffar, Aniqa Tehreem, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 6, 2017
Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipientBehnam Saberi, James P Hamilton, Christine M Durand, et al.
Annals of Transplantation|September 23, 2017
Single-Center Experience in Pre-transplant Hepatitis C Virus (HCV) Treatment Among Living Donor Liver Transplant Candidates: Bridging the Direct-Acting Antivirals (DAA)Ashwini M Niranjan-Azadi, Gokhan Kabacam, Christine M Durand, et al.
JAMA Network Open|December 4, 2020
Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver TransplantationBen L Da, Ghideon Ezaz, Tatyana Kushner, et al.
Pageof 9